MMD patients with a history of statins had significantly lower levels of CHO, LDL, APOA1, APOA2, and non‐HDL, whereas they had higher levels of TG, APOC2, APOC3, APOE, oxLDL, sdLDL, RC, and Hcy, compared with HCs (p < 0.05 for all comparisons) (Figure S1). The gene discussed is APOA2; the disease is multiminicore myopathy.